mAb-conjugated GYS1-targeting siRNA (Avidity Biosciences)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAb-conjugated GYS1-targeting siRNA (Avidity Biosciences)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionTransferrin receptor protein 1 modulatorsGlycogen synthase 1 inhibitors

TargetsGlycogen synthase 1Transferrin receptor protein 1

Therapy Area/IndicationsGlycogen Storage Disease Type II

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAvidity Biosciences Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAvidity Biosciences Inc

Active IndicationsN/A

Inactive IndicationsGlycogen Storage Disease Type II

Other Information

ATC CodeN/A